Dash Bio is a preclinical and clinical bioanalysis company that leverages a fully automated bioanalysis platform to enhance the speed, precision, and scalability of drug development. The company focuses on transforming the drug development process through innovative tech-enabled services, aiming to streamline and accelerate bioanalytical workflows.
Leadership & Board
Current Number of Employees29
Current LinkedIn Followers4,741
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$18M
Total Amount Raised$18M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$7M
Latest Funding Amount$7M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Dash Bio had 29 employees as of April 6, 2026. The number of employees increased by 3 (11.54%) week-over-week.
29Latest Employee Count
3(11.54%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Dash Bio had 4,741 followers as of April 6, 2026. The number of followers increased by 36 (0.77%) week-over-week.
4,741Latest Followers Count
36(0.77%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.